The Associate Director, Finance - US Immunology Forecasting & Strategic Finance will play a critical role within the US Immunology Consolidations team. Reporting to the Finance Director, US Immunology Sales Forecasting, this individual will serve as a key forecasting and finance leader responsible for supporting the consolidation, harmonization, governance, and continuous enhancement of Immunology revenue forecasts across all therapeutic areas and brands.
This position will support strategic and ad hoc initiatives across the Immunology organization, including portfolio assessments, launch readiness evaluations, forecasting transformation efforts, operational excellence projects, executive reporting, and cross-TA business analyses. The role offers significant visibility to senior commercial and finance leadership and requires the ability to influence decision-making across multiple functions and organizational levels.
In addition to the above, this role combines deep sales forecasting expertise with strong financial planning, analytical leadership, and cross-functional business partnering capabilities. The Associate Director will work closely with forecasting teams supporting RINVOQ, SKYRIZI, HUMIRA and future Immunology assets, helping ensure consistency of forecasting methodologies, assumptions, reporting standards, and business insights across the portfolio.
Responsibilities
Serve as a trusted finance, forecasting, and strategic planning partner to teams across Dermatology, Rheumatology, Gastroenterology, and future Immunology growth areas.
Lead complex, high-visibility, cross-functional initiatives spanning Commercial, Finance, Market Access, Marketing, Operations, ABI/MABI, Demand Planning, and Business Development.
Develop and consolidate Immunology sales forecasts for executive reviews, earnings preparation, corporate submissions, and strategic planning discussions.
Serve as a forecasting subject matter expert, applying advanced methodologies such as patient-flow modeling, analogs, epidemiology-based models, regression techniques, and market analytics.
Evaluate market events, competitive dynamics, reimbursement trends, prescribing patterns, and emerging commercial opportunities to inform forecast assumptions.
Lead scenario planning, sensitivity analyses, and risk assessments to assess business performance, forecast uncertainty, and potential growth drivers.
Support forecasting and financial analyses for product launches, lifecycle planning, indication expansions, pipeline transitions, portfolio assessments, and business development opportunities.
Analyze actual performance relative to forecasts, identifying key business drivers, risks, trends, and opportunities for corrective action.
Partner with Immunology Controllers, Commercial Finance, Commercial leadership, and cross-functional stakeholders to translate market developments into financial implications and strategic recommendations.
Lead high-priority ad hoc analyses and develop executive-ready presentations and decision-support materials for Immunology leadership.
Drive operational excellence and strategic transformation by simplifying, standardizing, automating, and scaling forecasting and financial planning processes, tools, and capabilities.
Champion knowledge sharing, best-practice adoption, AI and forecasting innovation, and analytical excellence while fostering an inclusive, collaborative, high-performing culture and influencing effectively across a matrixed organization.